Zenicor Medical Systems AB
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provide… Read more
Zenicor Medical Systems AB (ZENI) - Total Liabilities
Latest total liabilities as of September 2025: Skr30.35 Million SEK
Based on the latest financial reports, Zenicor Medical Systems AB (ZENI) has total liabilities worth Skr30.35 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zenicor Medical Systems AB - Total Liabilities Trend (2020–2024)
This chart illustrates how Zenicor Medical Systems AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zenicor Medical Systems AB Competitors by Total Liabilities
The table below lists competitors of Zenicor Medical Systems AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Moab Minerals Ltd
AU:MOM
|
Australia | AU$1.38 Million |
|
Diamcor Mining Inc
OTCQB:DMIFF
|
USA | $10.79 Million |
|
MACQUARIE GRP
MU:4M4
|
Germany | €369.41 Billion |
|
CARLSBERG -B- - Dusseldorf Stock Exchang
DU:CBGB
|
Germany | €86.08 Billion |
|
Capital Appreciation Ltd
JSE:CTA
|
South Africa | ZAC326.06 Million |
|
AMERICAN FINCL GRP
BE:QFI
|
Germany | €25.53 Billion |
|
Media Investment Optimization SL
MC:MIO
|
Spain | €33.90 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Zenicor Medical Systems AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zenicor Medical Systems AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zenicor Medical Systems AB (2020–2024)
The table below shows the annual total liabilities of Zenicor Medical Systems AB from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr34.75 Million | +17.20% |
| 2023-12-31 | Skr29.65 Million | +0.09% |
| 2022-12-31 | Skr29.62 Million | +32.35% |
| 2021-12-31 | Skr22.38 Million | +43.89% |
| 2020-12-31 | Skr15.56 Million | -- |